Recent Articles

• 
  Medical / Research

  IBS Team Uncovers Neuron-Astrocyte Mechanism in Brain Development

  The Institute for Basic Science (IBS) announced on the 10th that a research team led by Chang-Jin Lee, Director of the Center for Cognition and Sociality, and Research Fellow Sung-Ho Hong has identified the mechanism by which star-shaped non-neuronal cells called astrocytes enable complex and precis

  2026.03.11
• 
  Medical / Research

  10g Albumin Drop Raises Death Risk 137%

  Sarcopenia is a major cause of falls and fractures in old age. This is why the management of albumin, which stores and transports amino acids that serve as raw materials for muscle production, is considered an important condition for health in later life. Getty Images Bank Albumin is often regarded

  2026.03.11
• 
  Biotech

  Seasonal Shifts Worsen Atopic Dermatitis, Skin Barrier Key

  During seasonal transitions, the skin dries out easily and becomes sensitive. This period is particularly prone to symptom aggravation for patients with atopic dermatitis. Getty Images Bank During seasonal transitions, sharp changes in temperature and humidity cause the skin to dry out easily and be

  2026.03.11
• 
  Global Expansion

  Samsung Biologics, Eli Lilly to Build Songdo Biotech Hub

  Samsung Biologics is partnering with Eli Lilly of the United States to establish a domestic base for a world-class open innovation program in Korea.Samsung Biologics announced on the 10th that it has signed an open innovation partnership with Eli Lilly to foster promising Korean biotech companies.Un

  2026.03.11
• 
  Biopharma

  HK inno.N, Tanabe Pharma Korea Sign Co‑Promotion Deal for New Anemia Drug ‘Badanem’

  HK inno.N CEO Kwak Dal-won (front row, center) and key officials pose for a commemorative photo at the contract ceremony. HK inno.N announced on the 10th that it held a domestic co-promotion contract signing ceremony with Tanabe Pharma Korea for “Vadanem Tablets” (ingredient name: vadadustat), a new

  2026.03.10
• 
  Biotech

  Japan Approves World’s First iPSC Therapy

  Japan has become the first country in the world to approve a treatment based on induced pluripotent stem cells (iPSCs). Twenty years after the emergence of iPS cells, expectations are rising that they will open a new horizon for intractable diseases that have been difficult to treat. On 6 March, Jap

  2026.03.10
• 
  Pharmaceutical R&D

  PharmaResearch Secures Korean Patent for PRD-101 Nanotech Cancer Drug

  PharmaResearch announced on the 6th that it has completed domestic patent registration for the “nucleic acid-mediated therapeutic delivery composition,” the core technology of its next-generation nano anticancer drug “PRD-101.”This patent concerns a DOT-based drug delivery composition, PharmaResearc

  2026.03.06
• 
  Clinical Trial

  Celltrion Psoriasis Drug Stekyma Matches Originator in 52-Week Trial

  The 52-week long-term Phase 3 global clinical trial data for Celltrion’s autoimmune disease treatment “Steqeyma (ingredient name: ustekinumab)” has been published in the international dermatology journal “Dermatologic Therapy.” Building on this, Celltrion plans to strengthen medical professionals’ c

  2026.03.06
• 
  Global Expansion

  SK Plasma Signs KRW 110 Billion Tech Transfer Deal with Protürk

  (From right) Kim Seung-joo, CEO of SK Plasma, Fatma Meriç, President of the Turkish Red Crescent, and Ilyas Hasim, CEO of Kizilay Yatirim, sign a technology transfer agreement and pose for a commemorative photo. SK Plasma SK Plasma announced on the 5th that it has signed a technology transfer and li

  2026.03.05
• 
  Clinical Trial

  Huons Lab Announces Preclinical Data on Subcutaneous Antibody, ADC Use

  Huons Lab announced on the 5th that it has confirmed the potential to convert antibodies and antibody-drug conjugates (ADCs) into subcutaneous (SC) injection formulations by using recombinant human-derived hyaluronidase.On the 4th (local time), at the annual meeting of the American Society for Clini

  2026.03.05